Видео ютуба по тегу Immunocore

Why Immunocore?
Why Immunocore?
IMC-M113V от Immunocore. Новый препарат для полного излечения ВИЧ-инфекции.
IMC-M113V от Immunocore. Новый препарат для полного излечения ВИЧ-инфекции.
ImmTAC molecules: a closer look
ImmTAC molecules: a closer look
Immunocore | Milton Park Company Spotlight
Immunocore | Milton Park Company Spotlight
Discover our newest Immunocore office in Gaithersburg
Discover our newest Immunocore office in Gaithersburg
Immunocore 8-K: My Take on These Key Leadership Changes
Immunocore 8-K: My Take on These Key Leadership Changes
Interview with Immunocore
Interview with Immunocore
How do ImmTAX molecules work?
How do ImmTAX molecules work?
Immunocore T cell killing assays
Immunocore T cell killing assays
Инвест обзор IPO Immunocore (IMCR)
Инвест обзор IPO Immunocore (IMCR)
Getting to Know Immunocore with Dr. Dar
Getting to Know Immunocore with Dr. Dar
Park People - Annelise Vuidepot, Immunocore | Milton Park
Park People - Annelise Vuidepot, Immunocore | Milton Park
Immunocore's Melanoma Drug Advances to Phase 2a Trial
Immunocore's Melanoma Drug Advances to Phase 2a Trial
Ep. 81 - Data-Driven Growth: Immunocore CEO Bahija Jallal on Expanding TCR Therapies
Ep. 81 - Data-Driven Growth: Immunocore CEO Bahija Jallal on Expanding TCR Therapies
Телеконференция по итогам второго квартала 2025 года компании Immunocore Holdings IMCR
Телеконференция по итогам второго квартала 2025 года компании Immunocore Holdings IMCR
🔴 Immunocore Holdings PLC-ADR IMCR Stock Trading Facts 🔴
🔴 Immunocore Holdings PLC-ADR IMCR Stock Trading Facts 🔴
Discover the UK birthplace of our TCR technology
Discover the UK birthplace of our TCR technology
How Immunocore + Gates Foundation Backed a Rare Cancer Drug
How Immunocore + Gates Foundation Backed a Rare Cancer Drug
Immunocore Holdings Q2 2025 Earnings Call
Immunocore Holdings Q2 2025 Earnings Call
Stephen Megit - Case Study: IMCgp100
Stephen Megit - Case Study: IMCgp100
Bethan Archer, Immunocore shares her views about attending Promega's Biologics Symposium 2023
Bethan Archer, Immunocore shares her views about attending Promega's Biologics Symposium 2023
Immunocore Holdings stock analysis - would ChatGPT buy or sell today? [June 2025]
Immunocore Holdings stock analysis - would ChatGPT buy or sell today? [June 2025]
IPO Immunocore Holdings | IPO Vor Biopharma | Прожарка компаний перед IPO | Freedom Finance и QBF
IPO Immunocore Holdings | IPO Vor Biopharma | Прожарка компаний перед IPO | Freedom Finance и QBF
60-second Stories: Martina Canestraro, PhD, Immunocore Limited
60-second Stories: Martina Canestraro, PhD, Immunocore Limited